High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group

N. Thielen, B. van der Holt, G.E.G. Verhoef, R.A.H.M. Ammerlaan, P. Sonneveld, J.J.W.M. Janssen, W. Deenik, J.H.F. Falkenburg, M.J. Kersten, H.A.M. Sinnige, M. Schipperus, A. Schattenberg, R.V. Kooy, W.M. Smit, I.W.T. Chu, P.J.M. Valk, G.J. Ossenkoppele, J.J. Cornelissen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1049-1056
JournalAnnals of Hematology
Issue number8
Publication statusPublished - 2013

Cite this